| Treatment | NPQ | qP | ETR | 1-qP |
---|---|---|---|---|---|
CY-1 | CK | 0.33 ± 0.0500a | 0.83 ± 0.0259a | 76.92 ± 3.1859b | 0.17 ± 0.0259a |
T1 | 0.30 ± 0.0040a | 0.81 ± 0.0054a | 83.13 ± 0.3890b | 0.19 ± 0.0054a | |
T2 | 0.35 ± 0.0492a | 0.83 ± 0.0115a | 85.32 ± 0.4507ab | 0.17 ± 0.0115a | |
T3 | 0.23 ± 0.0261a | 0.86 ± 0.0052a | 88.35 ± 1.1659ab | 0.14 ± 0.0052a | |
T4 | 0.32 ± 0.0844a | 0.80 ± 0.0165a | 81.45 ± 0.1945b | 0.20 ± 0.0165a | |
T5 | 0.36 ± 0.0299a | 0.85 ± 0.0024a | 97.77 ± 6.9963a | 0.15 ± 0.0024a | |
CY-2 | CK | 0.60 ± 0.1575a | 0.63 ± 0.0879c | 76.92 ± 2.9566b | 0.37 ± 0.0879a |
T1 | 0.45 ± 0.0496a | 0.72 ± 0.0092bc | 82.80 ± 0.8351b | 0.28 ± 0.0092ab | |
T2 | 0.52 ± 0.0495a | 0.80 ± 0.0654abc | 84.99 ± 1.4417b | 0.20 ± 0.0654abc | |
T3 | 0.48 ± 0.0038a | 0.92 ± 0.0253a | 88.68 ± 2.0187ab | 0.08 ± 0.0253c | |
T4 | 0.48 ± 0.1105a | 0.83 ± 0.0141ab | 79.45 ± 0.6954b | 0.17 ± 0.0141bc | |
T5 | 0.67 ± 0.0476a | 0.87 ± 0.0072ab | 99.44 ± 1.1567a | 0.13 ± 0.0072bc |